Study of Cap.Saptarangi in insulin resistance associated with obesity.

A single arm study of PCOS to evaluate efficacy of Cap.Saptarangi in insulin resistance associated with obesity. - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/066442

Enrollment

Registered

2024-04-29

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N830- Follicular cyst of ovary

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patient age group from 20-45 years (upto menopause). 2) Including Both unmarried & married patients. 3) All obese patients with BMI 30 and above. 4) An Obese patients with irregular menses With scanty bleeding. 5) Obesed patients with Increased Random BSL.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
A single arm study of PCOS to evaluate efficacy of Cap.Saptarangi in insulin resistance associated with obesity.Timepoint: 13 weeks	—

Secondary

Measure	Time frame
Regular mensesTimepoint: 3 months of treatment	—

Countries

India

Contacts

Public ContactDr Tinku Ganesh Prabhu Khalche

Hon Shri Annasaheb Dange Ayurvedic Medical College,Post Graduation Research Centre Ashta

tinkuganeshkhalache@gmail.com919423041730

Outcome results